Aulnay-sous-Bois, France

Bernard Matra

This inventor holds 1 USPTO granted patent. Top assignee: Roussel Uclaf. Active years: 1980.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1980

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bernard Matra: Innovator in Therapeutic Steroids

Introduction

Bernard Matra is a notable inventor based in Aulnay-sous-Bois, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel steroid derivatives. His work has implications for the preparation of therapeutically active steroids.

Latest Patents

Matra holds a patent for "4,5-Seco-estrane-3,5,17-trione derivatives." This patent describes novel 4,5-seco-estrane-3,5,17-trione derivatives of the formula wherein R₁ is an alkyl group of 1 to 3 carbon atoms, R₂ is selected from the group consisting of hydrogen and alkyl groups of 1 to 5 carbon atoms, and K and K' are individually blocked ketones in the form of ketals. These compounds serve as intermediates for the preparation of therapeutically active steroids and their preparation, along with novel intermediates.

Career Highlights

Bernard Matra has had a distinguished career, working at Roussel Uclaf, a company known for its focus on pharmaceutical innovations. His expertise in medicinal chemistry has allowed him to contribute to the development of important therapeutic agents.

Collaborations

Throughout his career, Matra has collaborated with notable colleagues, including Jean Jolly and Primo Rizzi. These collaborations have further enhanced the impact of his work in the field of steroid chemistry.

Conclusion

Bernard Matra's contributions to the field of medicinal chemistry, particularly through his patent on steroid derivatives, highlight his role as an innovator in therapeutic applications. His work continues to influence the development of new medicinal compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…